1. Zhang, Mingpeng, Kan, Duo, Zhang, Boya, Niu, Yuanjie, Shang, Zhiqun. 2023. P300/SP1 complex mediating elevated METTL1 regulates CDK14 mRNA stability via internal m7G modification in CRPC. In Journal of experimental & clinical cancer research : CR, 42, 215. doi:10.1186/s13046-023-02777-z. https://pubmed.ncbi.nlm.nih.gov/37599359/
2. Parmasad, Jean-Louis A, Ricke, Konrad M, Nguyen, Benjamin, Ryan, Scott D, Rousseaux, Maxime W C. 2024. Genetic and pharmacological reduction of CDK14 mitigates synucleinopathy. In Cell death & disease, 15, 246. doi:10.1038/s41419-024-06534-8. https://pubmed.ncbi.nlm.nih.gov/38575601/
3. Sun, Yunpeng, Wang, Pengfei, Zhang, Qiyu, Wu, Huanhuan. 2021. CDK14/β-catenin/TCF4/miR-26b positive feedback regulation modulating pancreatic cancer cell phenotypes in vitro and tumor growth in mice model in vivo. In The journal of gene medicine, 24, e3343. doi:10.1002/jgm.3343. https://pubmed.ncbi.nlm.nih.gov/33871149/
4. Wu, Peng-Fei, Tang, Xiao-Ming, Sun, Hai-Lang, Ma, Jian, Kong, Ying-Hui. 2021. Depletion of circRNA circ_CDK14 inhibits osteosarcoma progression by regulating the miR-520a-3p/GAB1 axis. In Neoplasma, 68, 798-809. doi:10.4149/neo_2021_201206N1319. https://pubmed.ncbi.nlm.nih.gov/34348465/
5. Wang, Chunyang, Wu, Dongmei, He, Maofang, Bai, Dan, Liang, Baihui. 2021. LncRNA NORAD accelerates the progression of non-small cell lung cancer via targeting miRNA-455/CDK14 axis. In Minerva medica, 113, 817-824. doi:10.23736/S0026-4806.21.07194-9. https://pubmed.ncbi.nlm.nih.gov/33764714/
智鼠故事 
